- Home
- KROS vs RWT Comparison
KROS vs RWT Comparison
Compare KROS & RWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | RWT |
|---|---|---|
| Founded | 2015 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 715.8M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | KROS | RWT |
|---|---|---|
| Price | $19.22 | $5.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $23.00 | $6.86 |
| AVG Volume (30 Days) | 365.3K | ★ 1.4M |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 12.37% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $246,718,000.00 | $120,897,000.00 |
| Revenue This Year | $6,924.79 | N/A |
| Revenue Next Year | N/A | $46.22 |
| P/E Ratio | $12.19 | ★ N/A |
| Revenue Growth | ★ 37798.31 | N/A |
| 52 Week Low | $9.12 | $4.68 |
| 52 Week High | $22.55 | $6.73 |
Technical Indicators
Market Signals| Indicator | KROS | RWT |
|---|---|---|
| Relative Strength Index (RSI) | 49.60 | 56.78 |
| Support Level | $18.33 | $5.63 |
| Resistance Level | $19.67 | $6.00 |
| Average True Range (ATR) | 0.70 | 0.16 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 70.37 | 72.79 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.